Animal models and state-of-art techniques

CNServices Ltd offers valid animal models and state-of-art techniques for the development of novel pharmacotherapies for epilepsy, stroke, and neurodegenerative diseases such as Alzheimer’s disease. All models have been validated in a research-based environment and published in international scientific journals. All services are carried out in a quality controlled manner and tailored to the customer's need.

Tailored service packages

CNServices Ltd's service portfolio includes packages to determine the therapeutic potential of compounds with neuroprotective, antiepileptic or functional recovery enhancing properties. Packages are designed to include: independent and complementary models, histological and functional outcome measures, the clinically relevant route of drug administration, and a time window for administration. Routine screening of drug efficacy can be supplemented by a more detailed characterization of drugs using electrophysiology, in vivo microdialysis or histological approaches.